ALICIA VILLANUEVA: Open Payments
NPI 1639764731 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 57 payments from 31 companies in 2025. Trend: 2023 $1,096 · 2024 $1,211 · 2025 $1,385
Food & beverage: $1,385
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $155 |
| Merck Sharp & Dohme LLC | 5 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $113 |
| Daiichi Sankyo Inc. | 4 | $112 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $68 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
Products named: KEYTRUDA, Nubeqa, Enhertu, RYBREVANT, Vanflyta, ORGOVYX, VERZENIO, OPDIVO.
Industry payments across TX — which companies pay providers there.
